Device 2cm Peripheral Cutting Balloon_pi

2cm Peripheral Cutting Balloon

Payments companies reported to CMS as associated with 2cm Peripheral Cutting Balloon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$21Kassociated payments (2023-2025)
101clinicians with associated payments
1company reporting

By year

2023 $1,617
2024 $7,820
2025 $11K

Payments reported as associated with 2cm Peripheral Cutting Balloon, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $5,840
Vascular Surgery $5,828
Cardiovascular Disease $3,962
Pain Medicine (Anesthesiology) $886
Preventive Medicine/Occupational Environmental Medicine $589
Surgery $518

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with 2cm Peripheral Cutting Balloon

These are the largest totals companies reported as associated with 2cm Peripheral Cutting Balloon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ramesh Gowda New York, NY Interventional Cardiology $1,555.03
Hugo Rosero New York, NY Cardiovascular Disease $1,345.94
Michael Dudkiewicz New York, NY Vascular Surgery $1,189.47
David O'Connor Hackensack, NJ Vascular Surgery $1,146.24
Charles Decarlo Bronx, NY Vascular Surgery $912.96
Pouya Mohajer Las Vegas, NV Pain Medicine (Anesthesiology) $845.70
John Francis Hennecken Brooklyn, NY Cardiovascular Disease $798.17
Adrian Nugent Zachary, LA Interventional Cardiology $740.85
Christopher Hatzis New York, NY Vascular Surgery $712.30
Claude Simon New York, NY Cardiovascular Disease $658.18

Prescribed 2cm Peripheral Cutting Balloon?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.